Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.44B | 6.70B | 6.65B | 5.00B | 3.64B | Gross Profit |
1.98B | 1.82B | 1.79B | 1.28B | 878.40M | EBIT |
719.00M | 740.00M | 775.00M | 425.00M | 185.50M | EBITDA |
913.00M | 894.00M | 924.00M | 511.00M | 319.00M | Net Income Common Stockholders |
411.00M | 371.00M | 581.00M | 225.00M | 37.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.00M | 1.00M | 177.00M | 1.00M | 380.90M | Total Assets |
5.87B | 5.07B | 4.91B | 4.43B | 3.59B | Total Debt |
2.51B | 2.07B | 1.63B | 1.62B | 2.39B | Net Debt |
2.50B | 2.07B | 1.46B | 1.62B | 2.01B | Total Liabilities |
4.10B | 3.54B | 2.50B | 2.60B | 2.92B | Stockholders Equity |
1.70B | 1.45B | 1.75B | 1.32B | 673.90M |
Cash Flow | Free Cash Flow | |||
586.00M | 1.03B | 376.00M | -51.00M | 207.90M | Operating Cash Flow |
621.00M | 1.07B | 401.00M | -31.00M | 219.80M | Investing Cash Flow |
-788.00M | -270.00M | -152.00M | -203.00M | -228.90M | Financing Cash Flow |
174.00M | -975.00M | -73.00M | -146.00M | 209.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $9.56B | 22.71 | 26.10% | ― | 11.03% | -0.85% | |
78 Outperform | $20.54B | 38.22 | 20.39% | 2.12% | 4.59% | -2.05% | |
77 Outperform | $44.47B | 38.71 | 33.04% | 2.06% | 2.71% | -0.63% | |
65 Neutral | $2.81B | 20.27 | 10.37% | ― | 3.71% | -49.38% | |
64 Neutral | $731.30M | 37.86 | -1.00% | 3.27% | -9.98% | -106.51% | |
63 Neutral | $11.85B | 27.86 | 33.41% | 1.48% | -4.16% | -15.44% | |
62 Neutral | $8.07B | 13.60 | 3.76% | 3.13% | 3.60% | -14.67% |